Dirk Haussecker's Biography

Dirk Haussecker, Consultant, RNAi Therapeutics Consulting

Dirk Haussecker studied molecular biology at the University of Edinburgh with a focus on RNA processing and plant RNAi (2000-2). For his doctoral studies at Oxford University (2002-5), he subsequently investigated the relationship between noncoding transcription in the beta globin gene cluster and RNAi-related epigenetic chromatin regulation. During his post-doctoral studies at Stanford University (2005-2009), he discovered, characterized and explored the therapeutic potential of 2 classes of small RNAs (tRNA-derived small RNAs and capped small RNAs). Due to his long-standing interest in the financial markets, he has been analyzing the maturation of and consulting for the RNAi Therapeutics industry which today is his main occupation.

RNA Therapeutics - The Silent Revolution

Wednesday, 16 October 2013 at 16:30

Add to Calendar ▼2013-10-16 16:30:002013-10-16 17:30:00Europe/LondonRNA Therapeutics - The Silent RevolutionSELECTBIOenquiries@selectbiosciences.com

After some trial and error, RNA Therapeutics are now emerging as a major therapeutic platform. While the explosion of genetic information is providing an abundance of targets, it is therapeutic RNA chemistry and delivery technologies that will determine how this revolution will unfold. This presentation will provide a sense of what is to come over the next 5 years.

Add to Calendar ▼2013-10-16 00:00:002013-10-17 00:00:00Europe/LondonEpigenetics, microRNAs and non Coding RNAs in DiseaseSELECTBIOenquiries@selectbiosciences.com

Conference Sponsors